Percutaneous removal of malignant mammographic lesions at stereotactic vacuum-assisted biopsy. Academic Article uri icon

Overview

abstract

  • PURPOSE: To determine whether complete percutaneous removal of a malignant lesion detected at mammography ensures complete excision of the carcinoma histopathologically. MATERIALS AND METHODS: A retrospective review was performed of 135 lesions in which stereotactic biopsy was performed with a directional, vacuum biopsy instrument and an 11-gauge probe followed by mammography. Carcinoma was diagnosed at stereotactic biopsy in 51 (38%) lesions. In 15 (29%) carcinomas, the lesion seen at mammography was removed at stereotactic biopsy. Surgical findings were available for correlation with biopsy and imaging findings in all 15 cases. Mammographic and histopathologic findings were reviewed. RESULTS: Mammographic findings were calcifications in 11 lesions and a mass in four lesions. The median lesion size was 0.7 cm (range, 0.2-1.4 cm), and the median number of biopsy specimens was 15 (range, 10-22 specimens). Histopathologic findings at stereotactic biopsy were ductal carcinoma in situ in 12 lesions and infiltrating ductal carcinoma in three. Surgery revealed residual carcinoma in 11 (73%) of 15 lesions, including all three infiltrating ductal carcinomas and eight of 12 ductal carcinoma in situ lesions. CONCLUSION: Complete removal of the mammographic lesion does not ensure complete excision of the carcinoma.

publication date

  • March 1, 1998

Research

keywords

  • Biopsy, Needle
  • Breast
  • Breast Neoplasms
  • Carcinoma in Situ
  • Carcinoma, Ductal, Breast

Identity

Scopus Document Identifier

  • 0031931765

Digital Object Identifier (DOI)

  • 10.1148/radiology.206.3.9494489

PubMed ID

  • 9494489

Additional Document Info

volume

  • 206

issue

  • 3